Iron dosing in kidney disease: inconsistency of evidence and clinical practice

The management of anemia in patients with chronic kidney disease (CKD) is difficult. The availability of erythropoiesis-stimulating agents (ESAs) has increased treatment options for previously transfusion-requiring patients, but the recent evidence of ESA side effects has prompted the search for com...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Nephrol Dial Transplant
Hlavní autoři: Gaweda, Adam E., Ginzburg, Yelena Z., Chait, Yossi, Germain, Michael J., Aronoff, George R., Rachmilewitz, Eliezer
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2015
Témata:
Cutting-Edge Renal Science
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4309189/
https://ncbi.nlm.nih.gov/pubmed/24821751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfu104
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky